Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Engler

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Texas Heart Institute Journal|August 6, 2000
In memoriam: Timothy Scott-BurdenD A Engler
Circulation|October 1, 1996
Use of vascular endothelial growth factor for therapeutic angiogenesisD A Engler
Experimental Cell Research|April 3, 2001
Nuclear accumulation of exogenous DNA fragments in viable cells mediated by FGF-2 and DNA release upon cellular injuryD He, W Casscells, D A Engler
FEBS Letters|October 1, 1990
Human epidermal growth factor. Distinct roles of tyrosine 37 and arginine 41 in receptor binding as determined by site-directed mutagenesis and nuclear magnetic resonance spectroscopyD A Engler, G T Montelione, S K Niyogi
Biochemistry|October 23, 1990
Biochemical properties of site-directed mutants of human epidermal growth factor: importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor bindingS R Campion, R K Matsunami, D A Engler, et al.
Photochemistry and Photobiology|January 1, 1992
Fluorescence studies with human epidermal growth factorC A Ghiron, M R Eftink, D A Engler, et al.
Molecular and Cellular Biology|May 1, 1991
Aromaticity at position 37 in human epidermal growth factor is not obligatory for activityD A Engler, M R Hauser, J S Cook, et al.
Biochemical and Biophysical Research Communications|February 24, 1997
Liposomal induction of NO synthase expression in cultured vascular smooth muscle cellsT Scott-Burden, D A Engler, C L Tock, et al.
Circulation|November 1, 1996
Genetically engineered smooth muscle cells as linings to improve the biocompatibility of cardiovascular prosthesesT Scott-Burden, C L Tock, J J Schwarz, et al.
The Journal of Biological Chemistry|February 5, 1992
Critical functional requirement for the guanidinium group of the arginine 41 side chain of human epidermal growth factor as revealed by mutagenic inactivation and chemical reactivationD A Engler, S R Campion, M R Hauser, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Texas Heart Institute Journal|August 6, 2000
In memoriam: Timothy Scott-BurdenD A Engler
Circulation|October 1, 1996
Use of vascular endothelial growth factor for therapeutic angiogenesisD A Engler
Experimental Cell Research|April 3, 2001
Nuclear accumulation of exogenous DNA fragments in viable cells mediated by FGF-2 and DNA release upon cellular injuryD He, W Casscells, D A Engler
FEBS Letters|October 1, 1990
Human epidermal growth factor. Distinct roles of tyrosine 37 and arginine 41 in receptor binding as determined by site-directed mutagenesis and nuclear magnetic resonance spectroscopyD A Engler, G T Montelione, S K Niyogi
Biochemistry|October 23, 1990
Biochemical properties of site-directed mutants of human epidermal growth factor: importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor bindingS R Campion, R K Matsunami, D A Engler, et al.
Photochemistry and Photobiology|January 1, 1992
Fluorescence studies with human epidermal growth factorC A Ghiron, M R Eftink, D A Engler, et al.
Molecular and Cellular Biology|May 1, 1991
Aromaticity at position 37 in human epidermal growth factor is not obligatory for activityD A Engler, M R Hauser, J S Cook, et al.
Biochemical and Biophysical Research Communications|February 24, 1997
Liposomal induction of NO synthase expression in cultured vascular smooth muscle cellsT Scott-Burden, D A Engler, C L Tock, et al.
Circulation|November 1, 1996
Genetically engineered smooth muscle cells as linings to improve the biocompatibility of cardiovascular prosthesesT Scott-Burden, C L Tock, J J Schwarz, et al.
The Journal of Biological Chemistry|February 5, 1992
Critical functional requirement for the guanidinium group of the arginine 41 side chain of human epidermal growth factor as revealed by mutagenic inactivation and chemical reactivationD A Engler, S R Campion, M R Hauser, et al.
Pageof 2